Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-up

医学 放射治疗 危险系数 阶段(地层学) 胸腺瘤 内科学 多元分析 胃肠病学 外科 置信区间 生物 古生物学
作者
Hugo López,Angela Botticella,Farid Belkhir,Benjamin Besse,Élie Fadel,Olaf Mercier,Antonin Lévy,C. Le Péchoux
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:195: 110272-110272 被引量:1
标识
DOI:10.1016/j.radonc.2024.110272
摘要

Purpose To assess the prognostic factors and patterns of failure of patients consecutively treated with surgery and postoperative radiation therapy (PORT) for thymic epithelial tumours (TET). Patients and methods Data from 192 TET patients who were operated and received PORT at a single centre from 1990 to 2019 was retrospectively analysed. Results Most patients had thymoma (77 %, B247%), were classified Masaoka-Koga stage III (35 %) or IV (32 %) and had a R0 (75 %) resection. Radiotherapy was delivered at a median dose of 50.4 Gy (range, 42–66 Gy; ≥ 60 Gy in 17 %), 63 (33 %) patients were treated by intensity-modulated radiation therapy and elective nodal radiotherapy was used for 37 %. At a median follow-up of 10.9 years, the 10-year overall survival (OS) and progression-free survival (PFS) rates were 62 % (95 % CI: 54–70 %) and 47 % (95 % CI: 39–55 %), respectively. Locoregional recurrence (LRR) occurred in 72/192 (38 %) patients, distributed as 6 local, 45 regional and 21 both local and regional. LRR were mainly located to the pleura: 66/72 (92 %) and 16/72 (22 %; 16/192 in total, 8 %) were in-field. Distant relapse (DR) were observed in 30 patients (16 %), resulting in 10-year locoregional (LRC) and distant control rates of 58 % (95 % CI: 50–66 %) and 82 % (95 % CI: 77–88 %), respectively. In the multivariate analysis, Masaoka-Koga stage (HR [hazard ratio]: 1.9; p = 0.001), thymic carcinomas/neuroendocrine tumours (TC) (HR: 1.6; p = 0.045) and ECOG PS > 1 (HR: 1.9; p = 0.02) correlated with poorer OS. Higher Masaoka-Koga stage (HR: 2.6; p < 0.001) associated with a decreased LRC but not R1 status (HR: 1.2; p = 0.5) or WHO histology classification. TC (HR: 3.4; p < 0.001) and a younger age (HR: 2.5; p = 0.02) correlated with DR. Conclusion Approximately one-third of the TET in our study experienced a LRR, mainly to the pleura, and 8% in total were in-field. The place of radiotherapy should be better defined in higher risk thymoma patients within prospective randomized studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
孤独衣完成签到,获得积分10
1秒前
尘南浔发布了新的文献求助10
1秒前
SciGPT应助mojie62采纳,获得10
2秒前
satchzhao完成签到,获得积分10
2秒前
稳重完成签到 ,获得积分10
3秒前
柠檬很酸发布了新的文献求助10
4秒前
屠夫9441完成签到 ,获得积分10
4秒前
liuuuuuu完成签到,获得积分10
4秒前
烟雨发布了新的文献求助10
4秒前
高高的天亦完成签到 ,获得积分10
5秒前
exquisite完成签到,获得积分10
5秒前
勤劳滑板完成签到 ,获得积分10
5秒前
merrylake完成签到 ,获得积分10
5秒前
安静的乐松完成签到,获得积分10
5秒前
小雯关注了科研通微信公众号
6秒前
单薄月饼完成签到,获得积分10
6秒前
晚灯君完成签到 ,获得积分10
6秒前
复杂真完成签到,获得积分10
7秒前
YamDaamCaa给标致绮露的求助进行了留言
7秒前
尘南浔完成签到,获得积分10
7秒前
66完成签到 ,获得积分10
8秒前
8秒前
9秒前
玺月洛离完成签到,获得积分10
10秒前
QhL完成签到,获得积分10
11秒前
Jane完成签到,获得积分10
12秒前
墨尔根戴青完成签到,获得积分10
12秒前
小张z完成签到,获得积分10
13秒前
小虫虫完成签到,获得积分10
15秒前
小甘看世界完成签到,获得积分0
15秒前
一切都会好起来的完成签到,获得积分10
15秒前
Beatrice完成签到,获得积分10
15秒前
Yep0672完成签到,获得积分10
16秒前
情怀应助哈利波特采纳,获得10
17秒前
17秒前
17秒前
郭慧娜完成签到,获得积分10
17秒前
猫与咖啡完成签到,获得积分10
17秒前
17秒前
善学以致用应助之诚采纳,获得10
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513406
关于积分的说明 11167631
捐赠科研通 3248853
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875150
科研通“疑难数据库(出版商)”最低求助积分说明 804671